Jo Anne Tucker
Biography
Jo Anne Tucker, Ph.D., is an Associate Project Scientist, Step IV, in the Department of Medicine at the University of California, Irvine. She received her Ph.D. in Microbiology, Immunology and Molecular Genetics from the University of Kentucky College of Medicine, where her dissertation focused on Foxp3 expression in non-small cell lung cancer. Following her doctoral work, Tucker completed a Cancer Research Training Fellowship at the National Cancer Institute's Laboratory of Tumor Immunology and Biology.
Tucker's research focuses on cancer immunotherapy and the development of therapeutic vaccines. Her work spans multiple cancer types, including lung, prostate, cervical, and melanoma, with particular emphasis on T cell-mediated immune responses and the tumor microenvironment. She has contributed to the development of protein nanoparticle-based vaccine platforms for cancer treatment, including work demonstrating curative efficacy when combined with checkpoint inhibitors in melanoma models. Tucker has also investigated the immunological and psychosocial aspects of cancer survivorship, examining relationships between immune profiles, cytokines, and quality of life in cancer survivors.
Tucker has authored or co-authored over 25 peer-reviewed publications and holds a patent for protein nanoparticles and combination therapy for cancer immunotherapy. Before joining UC Irvine in 2013, she worked in clinical laboratory settings at the University of Kentucky Hospital, where she gained experience in immuno-molecular pathology and cytology. She is a member of the American Association for Cancer Research and the Society for Immunotherapy of Cancer.
Return to topEducation
- B.S. in Biology, Chemistry minor, Eastern Kentucky University, 1997
- Ph.D. in Microbiology, Immunology and Molecular Genetics, University of Kentucky, College of Medicine, 2010
Distinctions
- Technology Transfer Award, NCI, 2012
- Cancer Research Training Fellowship, National Cancer Institute, Laboratory of Tumor Immunology and Biology, 2013
- National Scholar Honor Society, 2006
- Delta Epsilon Iota Honor Society, 2006
- Regent's Scholarship, Eastern Kentucky University, 1992
- Employee of the Month, University of Kentucky Hospital, 2002
Areas of Expertise
- Cancer Immunotherapy
- Regulatory T Cell Biology
- Tumor Antigen Identification
- Prostate Cancer Immunology
- Protein Nanoparticle Vaccines
- Checkpoint Inhibitor Combinations
- Psychosocial Oncology Biomarkers
Recent Publications
- Li E, Butkovich N, Tucker JA, Nelson EL, Wang SW, “Evaluating Anti-tumor Immune Responses of Protein Nanoparticle-Based Cancer Vaccines” (opens in new tab), Methods in Molecular Biology, vol. 2671, pp. 321-333, 2023.
- Butkovich N, Tucker JA, Ramirez A, Li E, Meli VS, Nelson EL, Wang SW, “Nanoparticle vaccines can be designed to induce pDC support of mDCs for increased antigen display” (opens in new tab), Biomaterials Science, vol. 11, no. 2, pp. 596-610, 2023.
- Agbayani CJ, Tucker JA, Nelson EL, Martinez F, Cortes H, Khoury D, Kain ZN, Lin C, Torno L, Fortier MA, “Immunological and psychosocial functioning in parents of children with cancer” (opens in new tab), Supportive Care in Cancer, vol. 30, no. 4, pp. 3379-3388, 2022.
- Tucker JA, Osann K, Hsieh S, Wahi A, Monk BJ, Wenzel L, Nelson EL, “Longitudinal Changes in Sleep: Associations with Shifts in Circulating Cytokines and Emotional Distress in a Cancer Survivor Population” (opens in new tab), International Journal of Behavioral Medicine, vol. 28, no. 1, pp. 140-150, 2021.
Most Cited Publications
- Molino NM, Neek M, Tucker JA, Nelson EL, Wang SW, “Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses” (opens in new tab), Biomaterials, vol. 86, pp. 83-91, 2016.
- Jochems C, Tucker JA, Tsang KY, Madan RA, Dahut WL, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J, “A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates” (opens in new tab), Cancer Immunology Immunotherapy, vol. 63, no. 4, pp. 407-18, 2014.
- Neek M, Tucker JA, Kim TI, Molino NM, Nelson EL, Wang SW, “Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses” (opens in new tab), Biomaterials, vol. 156, pp. 194-203, 2018.
- Molino NM, Neek M, Tucker JA, Nelson EL, Wang SW, “Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells” (opens in new tab), ACS Biomaterials Science and Engineering, vol. 3, no. 4, pp. 496-501, 2017.
- Takai S, Schlom J, Tucker J, Tsang KY, Greiner JW, “Inhibition of TGF-β1 signaling promotes central memory T cell differentiation” (opens in new tab), Journal of Immunology, vol. 191, no. 5, pp. 2299-307, 2013.
- Tucker JA, Jochems C, Boyerinas B, Fallon J, Greiner JW, Palena C, Rodell TC, Schlom J, Tsang KY, “Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis” (opens in new tab), Cancer Immunology Immunotherapy, vol. 63, no. 12, pp. 1307-17, 2014.
- Jochems C, Tucker JA, Vergati M, Boyerinas B, Gulley JL, Schlom J, Tsang KY, “Identification and characterization of agonist epitopes of the MUC1-C oncoprotein” (opens in new tab), Cancer Immunology Immunotherapy, vol. 63, no. 2, pp. 161-74, 2014.
- Yannelli JR, Tucker JA, Hidalgo G, Perkins S, Kryscio R, Hirschowitz EA, “Characteristics of PBMC obtained from leukapheresis products and tumor biopsies of patients with non-small cell lung cancer” (opens in new tab), Oncology Reports, vol. 22, no. 6, pp. 1459-71, 2009.
- Neek M, Tucker JA, Butkovich N, Nelson EL, Wang SW, “An Antigen-Delivery Protein Nanoparticle Combined with Anti-PD-1 Checkpoint Inhibitor Has Curative Efficacy in an Aggressive Melanoma Model” (opens in new tab), Advanced Therapeutics, vol. 3, no. 12, 2020.
- Tucker JA, Jochems C, Gulley JL, Schlom J, Tsang KY, “Immunotherapy: shifting the balance of cell-mediated immunity and suppression in human prostate cancer” (opens in new tab), Cancers (Basel), vol. 4, no. 4, pp. 1333-48, 2012.
This profile was created with the help of AI.
Last updated on 3/7/2026.